Head and Neck Cancer
Clinical OncologyOtolaryngologyGeneral Surgery
Head and neck cancer is a collective term for cancers that occur in various upper respiratory tract tissues. Depending on the site of occurrence, it can be divided into oral cancer, nasopharyngeal cancer, oropharyngeal cancer, hypopharyngeal cancer, and laryngeal cancer. The most common tumour type in head and neck cancer is squamous cell carcinoma, which originates from squamous cells on the mucosal surface of the head and neck.
According to medical research, some head and neck cancers are associated with HPV (human papillomavirus).
Location of Head and Neck Cancers
Oral Cancer | Oral cancer refers to malignant tumours that grow within the oral cavity, including the lips, teeth, gums, the front two-thirds of the tongue, the floor of the mouth beneath the tongue, the hard palate, the gums, and the area behind the wisdom teeth. |
Tongue Cancer | Tongue cancer is a type of head and neck cancer and a subtype of oral cancer. It specifically refers to cancer cells found on the tongue and its base. |
Oropharyngeal Cancer | Oropharyngeal cancer occurs in the oropharynx, located at the back of the oral cavity and includes the base of the tongue, tonsils, soft palate, pharyngeal wall, and uvula. |
Nasopharyngeal Cancer | Nasopharyngeal cancer develops in the nasopharynx, the area at the central head, between the nasal cavities and above the soft palate, with the nasal cavity and sinuses in front and the oral cavity below. |
Pharyngeal Cancer | Pharyngeal cancer refers to cancers that grow in the pharynx, a muscular tube located behind the nose and above the neck, and it generally encompasses the growth of squamous cells in that region. |
Data of Head & Neck Cancer
- In a global gender analysis of HPV-related head and neck cancer, it is evident that the incidence rate among males is significantly higher than that among females. In the 2018 Cancer Annual Report, the incidence rate of oropharyngeal cancer (standardized to the 2000 World Population Age Standard) in males was 8.37 per 100,000, surpassing 7.85 per 100,000 for female cervical cancer.
- According to data from The Hong Kong Cancer Registry (HKCaR), in 2020, two-thirds of head and neck cancer patients (including lip, tongue, salivary glands, oral cavity, tonsils, oropharynx, hypopharynx, other unspecified oral sites, nasal cavity, middle ear, and paranasal sinuses) were males.
- From 2010 to 2020, the incidence of new head and neck cancer cases in Hong Kong increased by 25%, and in 2020, two out of every three new cases were males. On the other hand, for local oropharyngeal cancer cases alone, 80% of the patients were males.
- Up to this day, the global incidence rate of HPV-related head and neck cancer in males remains significantly higher than in females. The composition of tonsil cells is highly similar to that of cervical cells, making them susceptible to continuous HPV infection, which can progress into tonsil cancer. Data shows that the number of HPV-related tonsil cancer cases is on the rise in China, Hong Kong, and Taiwan, with approximately 60-70% of tonsil cancer cases being HPV-related, approaching the proportions seen in Western countries.
Symptoms
- The symptoms of head and neck cancer vary depending on the primary site of origin:
- If the primary site is in the oral cavity, it may present as ulcers inside the mouth that are difficult to heal and painful.
- If it's in the oropharynx, it can lead to difficulty swallowing, bad breath, discomfort and pain in the throat.
- If it's in the hypopharynx or throat, it might cause hoarseness, painful swallowing, difficulty swallowing, or the appearance of a lump in the neck.
- Enlargement of neck lymph nodes can also be a common symptom of head and neck cancer. Different primary locations of head and neck cancer may lead to enlargement of lymph nodes in different areas, and this should be closely monitored.
Because symptoms can vary depending on the primary site, it is essential to consult a doctor for an examination if you experience the above-mentioned symptoms to avoid missing the opportunity for treatment.
Prevention
Infection with the Human Papillomavirus (HPV) is one of the causes of head and neck cancer:
- HPV is primarily transmitted through sexual contact, coming into contact with skin wounds, mucous membranes, or infected bodily fluids. In addition to genital areas, oral sex can lead to oral HPV infection. Prolonged HPV infection that the body cannot clear on its own may lead to head and neck cancer, affecting both men and women.
- Research in the United States has shown more cases of HPV-related oropharyngeal cancer in males than in females. This is because males engage in more relative sexual behaviour than females, increasing their chances of detecting HPV infection in the oral cavity.
There is no routine oral HPV screening for head and neck cancer, and most cases are diagnosed in later stages, significantly affecting a patient's appearance and social life after treatment. Therefore, it is advisable to receive the HPV vaccine early as a preventive measure against HPV-related head and neck cancer.
Diagnosis and Treaments
Diagnosis
When the doctor suspects a patient may have head and neck cancer, they will recommend a tissue examination to determine the presence of cancerous cell changes. This is typically performed by an otolaryngologist (ear, nose, and throat specialist) using an endoscope. Suppose the otolaryngologist deems taking a tissue sample with an endoscope is inappropriate. In that case, the doctor may arrange other relevant tests based on the severity of the patient's condition and specific needs. These additional tests may include imaging studies of the head and neck (such as CT scans or MRIs), chest examinations, abdominal examinations, and various blood tests. These tests help provide a comprehensive understanding of the patient's condition at an early stage and assess whether there is any cancer cell metastasis.
Treatments
Surgical Treatment | Before undergoing surgical treatment, all head and neck cancer patients should be evaluated by a specialist to determine if surgery is suitable for them. The evaluation includes assessing whether the patient can tolerate the surgical risks, whether the primary tumour can be removed entirely, whether neck lymph node dissection is needed, and whether post-operative complications might affect pharyngeal function. |
Chemotherapy | Chemotherapy involves using drugs that circulate throughout the body, killing cancer cells that have spread to other parts of the body and inhibiting the expansion of cancer cells. It is a systemic treatment. While chemotherapy can treat various cancers, not all drugs have the same anti-cancer effects. Similar to surgery, chemotherapy is often combined with other therapies. |
Targeted Therapy | Unlike chemotherapy, targeted therapy uses specific drugs that "target" the genetic mutations in cancer cells to inhibit their activity or induce self-destruction. This process does not interfere with normal cells because it precisely targets the proteins and DNA of cancer cells. |
Immunotherapy | Immunotherapy is a form of biological therapy that employs substances the body generates to detect and destroy cancer cells and inhibit their growth. Immunotherapy can stimulate the immune system to enhance its defence capabilities or help restore and boost the body's immune system to detect and attack cancer cells. |
*The treatment plan should be determined through consultation between the doctor and the patient, considering the specific circumstances of the cancer.
Rferences
1. de Martel C, et al. Lancet Global Health. 2020;8:e180-e190
2, 3. Hong Kong Cancer Registry, Hong Kong Authority. Available at: https://www3.ha.org.hk/cancereg/allagesresult.asp.
4. American Cancer Society. Key Statistics for Oral Cavity and Oropharyngeal Cancers. Available at: https://www.cancer.org/cancer/oral-cavity-and-oropharyngeal-cancer/about/key-statistics.html.
HEAL Oncology Centre
We provide a variety of treatment options for head and neck cancers, including surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, and traditional Chinese medicine. Our multidisciplinary team of specialists will tailor the best treatment plan for each patient, providing comprehensive and holistic care to ensure you receive the best possible outcomes and support throughout your cancer treatment journey.
HEAL Oncology Centre
16/F, Entertainment Building, 30 Queens Road Central, Central, Hong Kong
Mon - Fri 9:00am - 6:00pm
Sat 9:00am - 1:00pm
Sun & Public Holidays Closed
Related Doctors
Dr Henry SZE Chun Kin
Specialist in Clinical Oncology
HEAL Oncology
Dr CHONG Hou Ming
Specialist in Otorhinolaryngology
HEAL Medical
Dr CHOW Chun Kuen
Specialist in Otorhinolaryngology
HEAL Medical
Dr Johnny LAU Kin Sang
Specialist in Clinical Oncology
HEAL Oncology
Dr Iris LEUNG Oi Sum
Specialist in Otorhinolaryngology
HEAL Medical
Dr LEUNG To Wai
Specialist in Clinical Oncology
HEAL Oncology
Dr Anna TAI Yin Ping
Specialist in Clinical Oncology
HEAL Oncology
CMP Keith KWAN Ching Ho
Registered Chinese Medicine Practitioner
HEAL Medical
HEAL Oncology
PhD Wendy WONG
Visiting Consultant of Registered Chinese Medicine Practitioner
HEAL Oncology
Related Services
Acute Appendicitis
Acute Cholecystitis
Anal Cancer
Related Articles
Here When You Need Us
HEAL Medical
A multi-specialty centre providing premium outpatient services for primary and specialist care.
Sat 9:00am - 1:00pm
Sun & Public Holidays Closed
HEAL Oncology
A boutique oncology centre providing comprehensive day procedure care.
Sat 9:00am - 1:00pm
Sun & Public Holidays Closed
HEAL Aesthetic
A doctor-led aesthetic centre with state of the art treatment devices.
Sat 10:00am - 4:00pm
Sun & Public Holidays Closed
HEAL Fertility
Providing world class reproductive medicine services in a friendly, non-judgemental environment.
Sat 9:00am - 1:00pm
Sun & Public Holidays Closed